MELVIN D. CHEITLIN; ROBERT BERNSTEIN; EDWARD A. LANGDON
In the last decade the use of radioactive iodine (I131) has come to occupy a place beside subtotal thyroidectomy as a definitive treatment for hyperthyroidism. The excellent results—comparable in every way to those obtained with surgery—coupled with the ease of administration, make this form of therapy most attractive. Furthermore, the absence of the surgical complications of recurrent laryngeal nerve injury and parathyroid ablation, infrequent as they are, gives radioactive iodine a distinct advantage over operation. The one great obstacle to the more general use of this substance, especially in the age group under 40, has been concern regarding the possibility
MELVIN D. CHEITLIN, ROBERT BERNSTEIN, EDWARD A. LANGDON. VARYING RESPONSES TO RADIOACTIVE IODINE (I131) THERAPY IN HYPERTHYROID PATIENTS(VARYING RESPONSES TO RADIOACTIVE IODINE (I131) THERAPY IN HYPERTHYROID PATIENTS*). Ann Intern Med. 1960;52:349–361. doi: 10.7326/0003-4819-52-2-349
Download citation file:
Published: Ann Intern Med. 1960;52(2):349-361.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use